Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a new revision entry v3.4.3 and deleted revision v3.4.2 from the record history.
    Difference
    0.1%
    Check dated 2026-03-05T18:29:46.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A new revision tag (v3.4.2) was added to the record history, replacing the previous v3.4.1, indicating a minor metadata update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T03:59:11.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision history shows a new Revision: v3.4.1 and removal of Revision: v3.4.0, a minor update to the page's revision log. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T01:52:07.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    UI changes include showing the glossary and color-coded diffs (green for additions, red for deletions) with a revision label (v3.4.0) on the record history page; these changes affect presentation rather than the substantive study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T22:09:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The record history shows a new revision entry v3.3.4 added and the previous revision v3.3.3 deleted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T06:43:54.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T20:56:47.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.